Leicestershire Medicines Strategy Group
Formerly known as Leicestershire Medicines Strategy Group
You are here: Home / Guidelines / Guidelines By Category / Malignant Disease
LLR APC Position Statement: Relugolix (Orgovyx®) for Hormone-Sensitive Prostate Cancer
